Author: Branwen Brockley
-
Prof Sir Shankar Balasubramanian Awarded Prestigious Royal Society of Chemistry Prize
Professor Sir Shankar Balasubramanian has received the Royal Society of Chemistry Khorana Prize, awarded for outstanding contributions through work at the chemistry and life science interface.
Read more -
Scientists create test to predict chemotherapy resistance
Scientists at the Cancer Research UK Cambridge Institute have created a test which can successfully predict whether cancer will resist common forms of chemotherapy treatment.
Read more -
Dr Hana Aliee appointed as a Junior Group Leader
At the Cancer Research UK Cambridge Institute, Dr Aliee will lead her team to develop new methods that uncover how gene expression and cellular behaviour change across environments, individuals, and disease states, advancing more personalised and inclusive healthcare solutions.
Read more -
Cambridge Institute Scientist Set For World Duathlon Championship
Great British athlete and Cancer Research UK Cambridge scientist Ian Hall is set to take part in World Duathlon Championships in Spain and raise funds for vital research.
Read more -
Study looks at radiotherapy to treat and diagnose children’s brain tumours and avoid invasive surgery
A world first Cancer Research UK study is looking at radiotherapy to treat and diagnose children's brain tumours and avoid invasive surgery.
Find out more -
Tony Davidge Shortlisted for National Papin Award for Outreach
Tony’s nomination recognises his longstanding commitment to openness around the use of animals in cancer research, and the crucial role this openness plays in fostering understanding and trust.
Read more -
Sir Shankar Balasubramanian elected Fellow of the AACR Academy
Sir Shankar has been recognised for his pioneering research in nucleic acid chemistry and his key role in the development of next-generation sequencing technology.
Find out more -
Richard Mair joins Institute as an Independent Clinical Fellow
Richard will build a research group at the Institute to focus on IDH mutant astrocytoma, , a common type of brain tumour that accounts for 9% of brain tumour diagnoses.
Find out more -
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
An MRI-based imaging technique developed at the Institute predicts the response of ovarian cancer tumours to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Find out more